<DOC>
	<DOCNO>NCT00822978</DOCNO>
	<brief_summary>This first-in-human phase 1 study assess ACHN-490 Injection safe people . Groups people receive either study medication ( ACHN-490 ) placebo ( normal saline ) single infusion . If single dose well tolerate group receive 1 dose per day 10 consecutive day . A new group people receive study medication high dose previous dose level long previous dose safe .</brief_summary>
	<brief_title>Phase 1 Study Safety ACHN-490</brief_title>
	<detailed_description />
	<criteria>Men woman Within normal weight limit In good health normal routine laboratory result Willing use medium player ( MP3 player ) device ear piece avoid exposure loud noise No ongoing medical condition heart disease , high blood pressure , asthma , diabetes , seizure , kidney problem No problem hear balance No previous injury surgery ears No family history hearing loss age 65 Not take medication birth control medication Smokers use tobacco product Recent blood donor Allergy ot iodine , shellfish aminoglycosides ( type antibiotic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>healthy</keyword>
	<keyword>volunteer</keyword>
	<keyword>subject</keyword>
</DOC>